Rafferty Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,724
| Closed | -$45K | – | 1014 |
|
|
2020
Q1 | $45K | Sell |
11,724
-87,884
| -88% | -$337K | ﹤0.01% | 578 |
|
|
2019
Q4 | $507K | Sell |
99,608
-29,792
| -23% | -$152K | 0.01% | 686 |
|
|
2019
Q3 | $654K | Sell |
129,400
-54,289
| -30% | -$274K | 0.01% | 614 |
|
|
2019
Q2 | $1.13M | Sell |
183,689
-12,328
| -6% | -$76K | 0.02% | 540 |
|
|
2019
Q1 | $910K | Buy |
+196,017
| New | +$910K | 0.01% | 568 |
|